Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases

Oncology

Volumn 68, Issue 4-6, 2005, Pages 371-374

  Notarnicola, Maria ^a   Altomare, Donato F ^b   Correale, Mario ^a   Ruggieri, Eustachio ^c   D'Attoma, Benedetta ^a   Mastrosimini, Anna ^a   Guerra, Vito ^a   Caruso, Maria G ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Colorectal cancer; Metastases; Serum lipids

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CALCULATION; CANCER PATIENT; CHOLESTEROL BLOOD LEVEL; COLORECTAL CANCER; COLORIMETRY; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METASTASIS; NUTRITIONAL STATUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COLORECTAL NEOPLASMS; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NUTRITIONAL STATUS; RISK FACTORS; SERUM ALBUMIN; TRIGLYCERIDES;

EID: 23844524749     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086977     Document Type: Article

References (25)

1. Kritchevsky SB, Kritchevsky D: Serum cholesterol and cancer risk: An epidemiologic perspective. Annu Rev Nutr 1992;12:391-416.
2. Alexopoulos CG, Blatsios B, Avgerinos A: Serum lipids and lipoprotein disorders in cancer patients. Cancer 1987;60:3065-3070.
3. Borrelli R, del Sordo G, De Filippo E, Contaldo F, Parisi V, Beneduce G: High serum HDL-cholesterol in pre- and post-menopausal women with breast cancer in southern Italy. Adv Exp Med Biol 1993;348:149-153.
4. Dessì S, Batetta B, Pulisci D, Spano O, Tessitore L, Costelli P, Baccino FM, Aroasio E, Pani P: Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 1994;73:253-258.
5. Knapp ML, Al-Sheibani S, Riches PG: Alterations of serum lipids in breast cancer: Effects of disease activity, treatment and hormonal factors. Clin Chem 1991;37:2093-2101.
6. Henriksson P, Eriksson M, Ericsson S, Rudling M, Stege R, Berglund L, Angelin B: Hypocholesterolemia and increased elimination of low-density lipoproteins in metastatic cancer of the prostate. Lancet 1989;ii:1178-1180.
7. Neugut AI, Johnsen CM, Daniel JF: Serum cholesterol levels in adenomatous polyps and cancer of the colon. JAMA 1986;255:365-367.
8. Forones NM, Falcao JB, Mattos D, Barone B: Cholesterolemia in colorectal cancer. Hepatogastroenterology 1998;45:1531-1534.
9. Kitayama J, Hatano K, Kaisaki H, Suzuki H, Fujiii S, Nagawa H: Hyperlipidemia is positively correlated with lymph node metastasis in men with early gastric cancer. Br J Surg 2001;91:191-198.
10. Meance S, Boutron-Ruault MC, Myara A, Gerhardt MF, Marteau P, Lavergne A, Franchisseur C, Bouley C and the Danpolyp Study Group: Fecal primary bile acids and serum cholesterol are associated with colorectal adenomas. Dig Dis Sci 2003;48:1751-1757.
11. Mehta N, Hordines J, Volpe C, Doerr R, Cohen SA: Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: A review of the evidence. Surg Oncol 1997;6:179-185.
12. Mehta N, Hordines J, Donald S, Doerr R, Cohen SA: Low density lipoproteins and Lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro. Clin Exp Metastasis 1998;16:587-594.
13. Friedewald WT, Levy RI, Fredrickson S: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Vitols S, Norgren S, Juliusson G, Tatidis L, Luthman H: Multilevel regulation of low density lipoprotein and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in normal and leukemic cells. Blood 1994;84:2689-2698.
15. Rao KN: The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis. Anticancer Res 1995;15:309-314.
16. Caruso MG, Osella AR, Notarnicola M, Berloco P, Leo S, Bonfiglio C, Di Leo A: Prognostic value of low density lipoprotein receptor expression in colorectal carcinoma. Oncol Rep 1998;5:927-930.
17. Caruso MG, Notarnicola M, Santillo M, Cavallini A, Di Leo A: Enhanced 3-HMGCoA reductase activity in human colorectal cancer not expressing low density lipoprotein receptor. Anticancer Res 1999;19:451-454.
18. Kusama T, Mukai M, Iwasaki T, Tatsuta M, Matsumoto Y, Akedo H, Inoue M, Nakamura H: 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastases. Gastroenterology 2002;122:308-317.
19. Bigler RD, Khoo M, Lund-Katz S, Scerbo L, Esfahani M: Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis. Proc Natl Acad Sci USA 1990;87:4981-4985.
20. Esfahani M, Bigler RD, Alfieri JL, Lund-Katz S, Baum JD, Scerbo L: Cholesterol regulates the cell surface expression of glycophospholipid-anchored CD14 antigen on human monocytes. Biochem Biophys Acta 1993;1149:217-223.
21. Stewart-Phillips JL, Lough J, Phillips NC: The effect of a high-fat diet on murine macrophage activity. Int J Immunopharmacol 1991;13:325-332.
22. McCarthy BM, Okano Y, Nakayasu T, Macy M, Watson SR, Harmony JA: Plasma lipoprotein and transferrin regulate the proliferation of a continuous T lymphocyte cell line. J Lipid Res 1987;28:1067-1077.
23. Cruse JP, Lewin MR, Clark CJ: Dietary cholesterol deprivation improves survival and reduces incidence of metastatic colon cancer in dimethylhydrazine-pretreated rats. Gut 1982;23:594-599.
24. Notarnicola M, Messa C, Pricci M, Guerra V, Altomare DF, Montemurro S, Caruso MG: Up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in left-sided human colon cancer. Anticancer Res 2004;24:3837-3842.
25. Jani JP, Specht S, Sternmler N, Blanock K, Singh SV, Gupta V, Katoh A: Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis. Invasion Metastasis 1993;13:314-324.